Related Experiment Video
Updated: Sep 25, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury
Won-Ho Kim1, Feng Hong, Svetlana Radaeva
1Section on Liver Biology, National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Interferon-gamma (IFN-gamma) has been implicated in liver damage in animal models and chronic hepatitis C infection; however, the underlying mechanism is not clear. Here we examined the role of STAT1, a key signaling molecule for IFN-gamma, in a model of murine hepatitis induced by the injection of LPS/D-galactosamine and in human hepatoma Hep3B cells. STAT1 is rapidly activated and highly induced after injection of LPS/D-galactosamine. Both overexpression of STAT1 and hepatocellular damage are located in the same pericentral region. Disruption of the STAT1 gene abolishes LPS/D-galactosamine-induced liver injury. Studies from IFN-gamma-deficient mice indicate that IFN-gamma is the major cytokine responsible for activation and hyperexpression of STAT1 in LPS/D-galactosamine-induced hepatitis. Hep3B cells overexpressing dominant negative STAT1 are resistant to IFN-gamma and IFN-gamma + TNF-alpha-induced cell death, whereas Hep3B cells overexpressing wild-type STAT1 are more susceptible to cell death. Taken together, these findings suggest that STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury.
Insights
Signal transducer and activator of transcription 1 (STAT1) is essential for liver damage in a mouse model of hepatitis. Interferon-gamma (IFN-gamma) drives STAT1 activation, leading to liver apoptosis and injury.
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- Interferon-gamma (IFN-gamma) is linked to liver damage in animal models and chronic hepatitis C.
- The precise mechanism of IFN-gamma-induced liver injury remains unclear.
- Signal transducer and activator of transcription 1 (STAT1) is a critical mediator of IFN-gamma signaling.
Purpose of the Study:
- To investigate the role of STAT1 in LPS/D-galactosamine-induced murine hepatitis.
- To elucidate the involvement of STAT1 in IFN-gamma-mediated liver injury.
- To determine the effect of STAT1 modulation on hepatocyte apoptosis and liver damage.
Main Methods:
- Induction of hepatitis in mice using lipopolysaccharide (LPS) and D-galactosamine.
- Analysis of STAT1 activation and expression in murine liver tissue.
- Assessment of liver injury in STAT1-deficient mice.
- Studies using human hepatoma Hep3B cells with manipulated STAT1 expression (wild-type and dominant-negative).
Main Results:
- STAT1 was rapidly activated and highly induced in the pericentral region of the liver following LPS/D-galactosamine injection.
- STAT1 gene disruption completely abolished LPS/D-galactosamine-induced liver injury.
- IFN-gamma was identified as the primary cytokine responsible for STAT1 activation and hyperexpression in this hepatitis model.
- Hep3B cells with dominant-negative STAT1 were resistant to IFN-gamma and IFN-gamma + TNF-alpha-induced cell death.
- Hep3B cells overexpressing wild-type STAT1 showed increased susceptibility to cell death.
Conclusions:
- STAT1 plays a crucial role in mediating liver apoptosis and injury induced by LPS/D-galactosamine.
- The IFN-gamma/STAT1 signaling pathway is a key driver of hepatocellular damage in this model.
- Targeting STAT1 may offer a therapeutic strategy for liver injury associated with hepatitis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Caspases
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway
